Prime Capital Investment Advisors, LLC Bausch Health Companies Inc. Transaction History

Prime Capital Investment Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$25.04 - $30.06 $265,574 - $318,816	-10,606 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$27.43 - $32.7 $87,666 - $104,509	3,196 Added 43.13%	10,606 $311,000
Q1 2020 May 04, 2020	SELL	$12.98 - $30.25 $7,528 - $17,545	-580 Reduced 7.26%	7,410 $115,000
Q4 2019 Feb 04, 2020	SELL	$18.89 - $31.89 $257,848 - $435,298	-13,650 Reduced 63.08%	7,990 $239,000
Q3 2019 Nov 05, 2019	SELL	$20.88 - $25.66 $4,802 - $5,901	-230 Reduced 1.05%	21,640 $473,000
Q2 2019 Aug 06, 2019	BUY	$20.52 - $26.45 $47,196 - $60,835	2,300 Added 11.75%	21,870 $552,000
Q1 2019 Apr 16, 2019	SELL	$20.23 - $26.29 $42,483 - $55,209	-2,100 Reduced 9.69%	19,570 $483,000
Q3 2018 Nov 13, 2018	BUY	$20.64 - $25.67 $447,268 - $556,268	21,670 New	21,670 $556,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.85B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Prime Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Prime Capital Investment Advisors, LLC with notifications on news.